IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
Weiwei Wu, Tiongsun Chia, Jia Lu, Xue Li, Jian Guan, Yaning Li, Fenggen Fu, Shuaixiang Zhou, Ye Feng, Junjie Deng, Jia Zou, Jiya Sun, Ying Yao, Xiaomin Ling, Zhihai Wu, Ying Zhang, Jinling Xu, Feifei Wang, Xue Liang, Min Wu, Huisi Liu, Bingliang Chen, Kaijie He
Topics & Concepts
IL-2 receptorAutocrine signallingCD8Interleukin 2Cancer researchImmunotherapyReceptorAgonistT cellImmunologyChemistryMedicineImmune systemInternal medicineCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy research